Classical Communication Over Quantum Multiple-Access Channel With Unreliable Entanglement Assistance
IEEE Transactions on Information Theory · 2026-06 · 72 (6) · 4073-4084
DOI: 10.1109/tit.2026.3680133 ↗Kurz gefasst
Fachartikel in der Zeitschrift IEEE Transactions on Information Theory, 2026-06. Verfasst von Xiaomin Liu und 1 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
We study classical communication over quantum multiple-access channels and their wiretap counterparts with unreliable entanglement assistance. Using a robust superposition coding scheme, we characterize the trade-off between baseline rates that are guaranteed without entanglement and additional rates achievable when entanglement is available. We establish a regularized characterization of the classical capacity region for the quantum multiple-access channel and extend it to regularized secrecy capacity regions under two models: entanglement loss and interception. Specifically, for the class of entanglement-breaking channels, we demonstrate that these regularized regions reduce to computable single-letter formulas.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, X., & Xi, Z. (2026). Classical Communication Over Quantum Multiple-Access Channel With Unreliable Entanglement Assistance. IEEE Transactions on Information Theory, 72(6), 4073-4084. https://doi.org/10.1109/tit.2026.3680133
Vancouver
Liu X, Xi Z. Classical Communication Over Quantum Multiple-Access Channel With Unreliable Entanglement Assistance. IEEE Transactions on Information Theory. 2026;72(6):4073-4084. doi:10.1109/tit.2026.3680133
BibTeX
@article{Liu2026,
author = {Liu, Xiaomin and Xi, Zhengjun},
title = {Classical Communication Over Quantum Multiple-Access Channel With Unreliable Entanglement Assistance},
journal = {IEEE Transactions on Information Theory},
year = {2026},
volume = {72},
number = {6},
pages = {4073--4084},
doi = {10.1109/tit.2026.3680133}
}
EUVIMED